5-Amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 98%, 25mg

N-((4-(4-PHENYLPIPERAZIN-1-YL)TETRAHYDRO-2H-PYRAN-4-YL)METHYL)-2-(PHENYLTHIO)NICOTINAMIDE, 95%, 25mg

(E,E)-1,4-Bis[4-[bis(4-methoxyphenyl)amino]styryl]benzene>98.0%(HPLC)(N)25g

Ethyl Pyrimidine-4-carboxylate>98.0%(GC)(T)25g

(S)-2-(5-(Dimethylamino)naphthalene-1-sulfonamido)-3-methylbutanoic acid, 1g

2-(1-(Prop-2-yn-1-yl)piperidin-4-yl)acetic acid, 95%, 100mg

tert-Butyldimethyl(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethoxy)phenoxy)silane, 98%, 1g

2-Amino-4-chloro-6-fluorobenzothiazole, 95.0%, 5g

2-Fluorobenzene-1,3-diol, 95.0%, 5g

4,2'-Dimethoxybenzophenone, 98.0%, 1g

1-Bromo-2,5-difluorobenzene, 98.0%, 1g

3,4-Dimetossibenzaldeide, minimo 99%, per sintesi, 100 g, confezione in plastica.

5-(2-Methylpropyl)-1,3-thiazol-2-amine, 97%, 5g